Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool

Immunity

Volumn 17, Issue 4, 2002, Pages 463-472

  Sitnicka, Ewa ^a   Bryder, David ^a   Theilgaard Mönch, Kim ^b   Buza Vidas, Natalija ^a   Adolfsson, Jörgen ^a   Jacobsen, Sten Eirik W ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; REGULATORY MECHANISM; STEM CELL; T LYMPHOCYTE;

EID: 0036797682     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00419-3     Document Type: Article

References (54)

1. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity. 15:2001;659-669.
2. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1997;1033-1041.
3. Akashi K., Reya T., Dalma-Weiszhausz D., Weissman I.L. Lymphoid precursors. Curr. Opin. Immunol. 12:2000;144-150. a.
4. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:2000;193-197. b.
5. Borge O.J., Ramsfjell V., Veiby O.P., Murphy M.J. Jr., Lok S., Jacobsen S.E. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. Blood. 88:1996;2859-2870.
6. Bryder D., Jacobsen S.E. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood. 96:2000;1748-1755.
7. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation. a simple method to isolate long-term stem cells Proc. Natl. Acad. Sci. USA. 98:2001;14541-14546.
8. Chklovskaia E., Jansen W., Nissen C., Lyman S.D., Rahner C., Landmann L., Wodnar-Filipowicz A. Mechanism of flt3 ligand expression in bone marrow failure. translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis Blood. 93:1999;2595-2604.
9. Chklovskaia E., Nissen C., Landmann L., Rahner C., Pfister O., Wodnar-Filipowicz A. Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A. Blood. 97:2001;1027-1034.
10. Dao M.A., Hannum C.H., Kohn D.B., Nolta J.A. FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood. 89:1997;446-456.
11. Dick J.E., Magli M.C., Huszar D., Phillips R.A., Bernstein A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell. 42:1985;71-79.
12. Domen J., Weissman I.L. Self-renewal, differentiation or death. regulation and manipulation of hematopoietic stem cell fate Mol. Med. Today. 5:1999;201-208.
13. Elwood N.J., Zogos H., Willson T., Begley C.G. Retroviral transduction of human progenitor cells. use of granulocyte colony-stimulating factor plus stem cell factor to mobilize progenitor cells in vivo and stimulation by Flt3/Flk-2 ligand in vitro Blood. 88:1996;4452-4462.
14. Geissler E.N., Russell E.S. Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. I. Influence upon hematopoietic stem cells. Exp. Hematol. 11:1983;452-460.
15. Godfrey D.I., Kennedy J., Suda T., Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150:1993;4244-4252.
16. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1991;1213-1225.
17. Ikuta K., Weissman I.L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA. 89:1992;1502-1506.
18. Ito T., Tajima F., Ogawa M. Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp. Hematol. 28:2000;1269-1273.
19. Jordan C.T., Lemischka I.R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 4:1990;220-232.
20. Keller G., Snodgrass R. Life span of multipotential hematopoietic stem cells in vivo. J. Exp. Med. 171:1990;1407-1418.
21. Keller J.R., Ortiz M., Ruscetti F.W. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood. 86:1995;1757-1764.
22. Kimura S., Roberts A.W., Metcalf D., Alexander W.S. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc. Natl. Acad. Sci. USA. 95:1998;1195-1200.
23. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672.
24. Lagasse E., Weissman I.L. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. 89:1997;1021-1031.
25. Lemieux M.E., Chappel S.M., Miller C.L., Eaves C.J. Differential ability of flt3-ligand, interleukin-11, and Steel factor to support the generation of B cell progenitors and myeloid cells from primitive murine fetal liver cells. Exp. Hematol. 25:1997;951-957.
26. Li C.L., Johnson G.R. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood. 84:1994;408-414.
27. Li C.L., Johnson G.R. Murine hematopoietic stem and progenitor cells. I. Enrichment and biologic characterization Blood. 85:1995;1472-1479.
28. Lyman S.D., Jacobsen S.E. c-kit ligand and Flt3 ligand. stem/progenitor cell factors with overlapping yet distinct activities Blood. 91:1998;1101-1134.
29. Lyman S.D., Seaberg M., Hanna R., Zappone J., Brasel K., Abkowitz J.L., Prchal J.T., Schultz J.C., Shahidi N.T. Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood. 86:1995;4091-4096.
30. Mackarehtschian K., Hardin J.D., Moore K.A., Boast S., Goff S.P., Lemischka I.R. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 3:1995;147-161.
31. -/- mice. Cell. 89:1997;1011-1019.
32. Matsunaga T., Kato T., Miyazaki H., Ogawa M. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells. comparison with the effects of FLT3/FLK-2 ligand and interleukin-6 Blood. 92:1998;452-461.
33. Matthews W., Jordan C.T., Wiegand G.W., Pardoll D., Lemischka I.R. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 65:1991;1143-1152.
34. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., Maliszewski C.R., Lynch D.H., Smith J., Pulendran B.et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 95:2000;3489-3497.
35. McKinstry W.J., Li C.L., Rasko J.E., Nicola N.A., Johnson G.R., Metcalf D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood. 89:1997;65-71.
36. Miller C.L., Eaves C.J. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc. Natl. Acad. Sci. USA. 94:1997;13648-13653.
37. Miller C.L., Rebel V.I., Lemieux M.E., Helgason C.D., Lansdorp P.M., Eaves C.J. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Exp. Hematol. 24:1996;185-194.
38. Moore T.A., Zlotnik A. T-cell lineage commitment and cytokine responses of thymic progenitors. Blood. 86:1995;1850-1860.
39. Morrison S.J., Uchida N., Weissman I.L. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:1995;35-71.
40. Okada S., Nakauchi H., Nagayoshi K., Nishikawa S., Miura Y., Suda T. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood. 78:1991;1706-1712.
41. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 273:1996;242-245. a.
42. Osawa M., Nakamura K., Nishi N., Takahasi N., Tokuomoto Y., Inoue H., Nakauchi H. In vivo self-renewal of c-Kit+ Sca-1+ Lin(low/-) hemopoietic stem cells. J. Immunol. 156:1996;3207-3214. b.
43. Petzer A.L., Zandstra P.W., Piret J.M., Eaves C.J. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells. novel responses to Flt3-ligand and thrombopoietin J. Exp. Med. 183:1996;2551-2558.
44. Piacibello W., Sanavio F., Garetto L., Severino A., Bergandi D., Ferrario J., Fagioli F., Berger M., Aglietta M. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 89:1997;2644-2653.
45. Rasko J.E., Metcalf D., Rossner M.T., Begley C.G., Nicola N.A. The flt3/flk-2 ligand. receptor distribution and action on murine haemopoietic cell survival and proliferation Leukemia. 9:1995;2058-2066.
46. Sitnicka E., Lin N., Priestley G.V., Fox N., Broudy V.C., Wolf N.S., Kaushansky K. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 87:1996;4998-5005.
47. Smith L.G., Weissman I.L., Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. Sci. USA. 88:1991;2788-2792.
48. Solar G.P., Kerr W.G., Zeigler F.C., Hess D., Donahue C., de Sauvage F.J., Eaton D.L. Role of c-mpl in early hematopoiesis. Blood. 92:1998;4-10.
49. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science. 241:1988;58-62.
50. Theilgaard-Monch K., Cowland J., Borregaard N. Profiling of gene expression in individual hematopoietic cells by global mRNA amplification and slot blot analysis. J. Immunol. Methods. 252:2001;175-189.
51. Veiby O.P., Jacobsen F.W., Cui L., Lyman S.D., Jacobsen S.E. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J. Immunol. 157:1996;2953-2960.
52. Wodnar-Filipowicz A., Lyman S.D., Gratwohl A., Tichelli A., Speck B., Nissen C. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood. 88:1996;4493-4499.
53. Yonemura Y., Ku H., Lyman S.D., Ogawa M. In vitro expansion of hematopoietic progenitors and maintenance of stem cells. comparison between FLT3/FLK-2 ligand and KIT ligand Blood. 89:1997;1915-1921.
54. Zeigler F.C., Bennett B.D., Jordan C.T., Spencer S.D., Baumhueter S., Carroll K.J., Hooley J., Bauer K., Matthews W. Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. Blood. 84:1994;2422-2430.